Back to Search
Start Over
Increased values of the circulating PDGFβ sustains the 'withdrawal syndrome' after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia
- Publication Year :
- 2015
- Subjects :
- Male
medicine.drug_class
Antineoplastic Agents
Pharmacology
Tyrosine-kinase inhibitor
Receptor, Platelet-Derived Growth Factor beta
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
medicine
Humans
In patient
Protein Kinase Inhibitors
Molecular Biology
Aged
business.industry
Myeloid leukemia
Proto-Oncogene Proteins c-sis
Hematology
Cell Biology
Middle Aged
Protein-Tyrosine Kinases
Molecular Medicine
Substance Withdrawal Syndrome
Discontinuation
Female
Withdrawal syndrome
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....efb25aa6c7a97e31dda00e8f077e3ef9